Form 4 for KRRO Korro Bio, Inc.
Accepted 2024-11-12 00:00:00 ET · period of report 2024-11-11 · accession 0000950170-24-125822 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2024-11-12 | 2024-11-11 | KRRO | Agarwal Vineet | CFO | S - Sale+OE | $70.00 | -800 | 0 | -100% | -$56.0K |
| DT | 2024-11-12 | 2024-11-11 | KRRO | Agarwal Vineet | CFO | M - OptEx | $11.68 | +800 | 800 | New | +$9,344 |
| DT | 2024-11-12 | 2024-11-11 | KRRO | Agarwal Vineet | CFO | M - OptEx | $0.00 | -800 | 30.8K | -3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-11 | S | D | 800 | $70.00 | 0 | D | — | — | |
| 2 | Common | Common Stock | 2024-11-11 | M | A | 800 | $11.68 | 800 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2024-11-11 | M | D | 800 | $0.00 | 30,807 | D | $11.68 · — to 2031-05-29 | 800 Common Stock | (F2) The shares subject to the option vest as to 25% of the shares on May 11, 2022, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date. |